M. Montes

发表

How do women living with HIV experience menopause? Menopausal symptoms, anxiety and depression according to reproductive age in a multicenter cohort

P. L. López, Miguel Ángel Martínez, D. Podzamczer, 2021, BMC Women's Health.

Virological outcome among HIV infected patients transferred from pediatric care to adult units in Madrid, Spain (1997–2017)

P. Soler-Palacín, Á. Holguín, J. Losa, 2020, Scientific Reports.

Sustained virological response to interferon plus ribavirin reduces non-liver-related mortality in patients coinfected with HIV and Hepatitis C virus.

J. Mallolas, C. Quereda, F. Pulido, 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Hypertension and Isolated Office Hypertension in HIV-Infected Patients Determined By Ambulatory Blood Pressure Monitoring: Prevalence and Risk Factors

J. Arribas, J. Peña, M. Montes, 2011, Journal of acquired immune deficiency syndromes.

Plasma IP-10 and IL-6 are linked to Child-Pugh B cirrhosis in patients with advanced HCV-related cirrhosis: a cross-sectional study

S. Resino, M. Jiménez-Sousa, J. Berenguer, 2020, Scientific Reports.

Eradication of hepatitis C virus and non‐liver‐related non–acquired immune deficiency syndrome–related events in human immunodeficiency virus/hepatitis C virus coinfection

C. Tural, J. Mallolas, M. Crespo, 2017, Hepatology.

Characteristics and Outcome of AIDS-Related Hodgkin Lymphoma Before and After the Introduction of Highly Active Antiretroviral Therapy

J. Ribera, J. Torre-Cisneros, R. Palacios, 2008, Journal of acquired immune deficiency syndromes.

Prognostic Value of Transient Elastography in Human Immunodeficiency Virus-Infected Patients With Chronic Hepatitis C

A. Rivero‐Juárez, A. Rivero, J. Berenguer, 2016, Open forum infectious diseases.

Prevalence of nonalcoholic fatty liver disease using noninvasive techniques among children, adolescents, and youths living with HIV

Á. Lancharro, A. Olveira, C. Díez, 2022, AIDS.

Failure of Cetirizine to Prevent Nevirapine-Associated Rash: A Double-Blind Placebo-Controlled Trial for the GESIDA 26/01 Study

J. Miro, J. Blanco, E. Ribera, 2004, Journal of acquired immune deficiency syndromes.

Impact of Antiretroviral Treatment Containing Tenofovir Difumarate on the Telomere Length of Aviremic HIV-Infected Patients

R. Perona, J. Arribas, J. Mingorance, 2017, Journal of Acquired Immune Deficiency Syndromes.

Genetic variants associated with steatohepatitis and liver fibrosis in HIV-infected patients with NAFLD

R. Montejano, M. Abadia, A. Olveira, 2022, Frontiers in Pharmacology.

Telomere Length Increase in HIV/HCV-Coinfected Patients with Cirrhosis after HCV Eradication with Direct-Acting Antivirals †

S. Resino, L. Ibáñez-Samaniego, M. Jiménez-Sousa, 2020, Journal of clinical medicine.

Effects of Hepatitis C Virus (HCV) Eradication on Bone Mineral Density in Human Immunodeficiency Virus/HCV-Coinfected Patients

M. Salavert, J. Navarro, A. Curran, 2020, Clinical Infectious Diseases.

High quality of life, treatment tolerability, safety and efficacy in HIV patients switching from triple therapy to lopinavir/ritonavir monotherapy: A randomized clinical trial

C. Hidalgo-Tenorio, M. Fariñas, F. Lozano, 2018, PloS one.

Clinical effects of viral relapse after interferon plus ribavirin in patients co-infected with human immunodeficiency virus and hepatitis C virus.

C. Tural, J. Mallolas, C. Quereda, 2013, Journal of hepatology.

Management of betablocked patients after sustained virological response in hepatitis C cirrhosis

M. Abadia, A. Olveira, M. Romero, 2019, World journal of gastroenterology.

Fatty liver disease in children living with HIV: a ghostly iceberg.

Á. Lancharro, A. Olveira, C. Díez, 2022, AIDS.

[Factors associated with hepatic steatosis in human immunodeficiency virus and hepatits C virus coinfected patients].

J. Arribas, J. Peña, J. Larrauri, 2009, Medicina clinica.

Effect of mono/dual antiretroviral therapy on suppression of HCV and HIV during treatment of HCV infection in HIV/HCV-coinfected patients

I. Jiménez-Nácher, F. Pulido, J. González-García, 2019, Enfermedades infecciosas y microbiologia clinica (English ed.).

Effect of mono/dual antiretroviral therapy on suppression of HCV and HIV during treatment of HCV infection in HIV/HCV-coinfected patients.

I. Jiménez-Nácher, F. Pulido, J. González-García, 2019, Enfermedades infecciosas y microbiologia clinica.

HAART is associated with lower hepatic necroinflammatory activity in HIV–hepatitis C virus-coinfected patients with CD4 cell count of more than 350 cells/μl at the time of liver biopsy

J. Arribas, J. Larrauri, J. González-García, 2009, AIDS.

Single (B or C), dual (BC or BD) and triple (BCD) viral hepatitis in HIV-infected patients in Madrid, Spain

S. Hernandez, M. Montes, A. Lorenzo, 2005, AIDS.

Effects of HIV Infection in Plasma Free Fatty Acid Profiles among People with Non-Alcoholic Fatty Liver Disease

J. Fontecha, J. Martínez-Sanz, M. Sánchez-Conde, 2022, Journal of clinical medicine.

Effectiveness of the combination elvitegravir/cobicistat/tenofovir/emtricitabine (EVG/COB/TFV/FTC) plus darunavir among treatment-experienced patients in clinical practice: a multicentre cohort study

D. Podzamczer, C. Vidal, B. Rodés, 2020, AIDS Research and Therapy.

Effectiveness and safety of first-line antiretroviral regimens in clinical practice: a multicentre cohort study.

Miguel Ángel Martínez, D. Podzamczer, C. Vidal, 2020, The Journal of antimicrobial chemotherapy.

Brief Report: Differential Effects of Tenofovir, Abacavir, Emtricitabine, and Darunavir on Telomerase Activity In Vitro

R. Perona, J. Arribas, J. Mingorance, 2017, Journal of acquired immune deficiency syndromes.

Lopinavir/Ritonavir as Single-Drug Therapy for Maintenance of HIV-1 Viral Suppression: 48-Week Results of a Randomized, Controlled, Open-Label, Proof-of-Concept Pilot Clinical Trial (OK Study)

A. Carcas, F. Gayá, J. Arribas, 2005, Journal of acquired immune deficiency syndromes.

Effectiveness, safety/tolerability of OBV/PTV/r ± DSV in patients with HCV genotype 1 or 4 with/without HIV-1 co-infection, chronic kidney disease (CKD) stage IIIb-V and dialysis in Spanish clinical practice – Vie-KinD study

J. Mallolas, M. Laguno, J. Losa, 2019, PloS one.

Incidence and risk factors for developing cytomegalovirus retinitis in HIV-infected patients receiving protease inhibitor therapy

C. Tural, R. Schuurman, J. Casado, 1999 .

Incidence and risk factors for developing cytomegalovirus retinitis in HIV-infected patients receiving protease inhibitor therapy. Spanish CMV-AIDS Study Group.

C. Tural, R. Schuurman, J. Casado, 1999, AIDS.

Experiences with long acting injectable ART: A qualitative study among PLHIV participating in a Phase II study of cabotegravir + rilpivirine (LATTE-2) in the United States and Spain

M. Murray, D. Kerrigan, D. Margolis, 2018, PloS one.

Plasma IP-10 and IL-6 are linked to Child-Pugh B cirrhosis in patients with advanced HCV-related cirrhosis: a cross-sectional study

S. Resino, M. Jiménez-Sousa, J. Berenguer, 2020, Scientific Reports.

Spontaneous viral clearance, viral load, and genotype distribution of hepatitis C virus (HCV) in European HIV-infected patients with anti-HCV antibodies.

J. Arribas, J. González-García, M. Montes, 2009, The Journal of infectious diseases.

Coformulated bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir with emtricitabine and tenofovir alafenamide, for initial treatment of HIV-1 infection (GS-US-380–1490): a randomised, double-blind, multicentre, phase 3, non-inferiority trial

K. White, H. Stellbrink, P. Sax, 2017, The Lancet.

Simplification to dual therapy (atazanavir/ritonavir + lamivudine) versus standard triple therapy [atazanavir/ritonavir + two nucleos(t)ides] in virologically stable patients on antiretroviral therapy: 96 week results from an open-label, non-inferiority, randomized clinical trial (SALT study)

B. Clotet, M. Odriozola, J. Olalla, 2017, The Journal of antimicrobial chemotherapy.

Lopinavir-Ritonavir Monotherapy Versus Lopinavir-Ritonavir and 2 Nucleosides for Maintenance Therapy of HIV: 96-Week Analysis

J. Arribas, R. Delgado, M. Pérez-Elías, 2009, Journal of acquired immune deficiency syndromes.

A. Ahumada, A. Olveira, J. Berenguer, 2017, AIDS.

Effects of frailty, geriatric syndromes, and comorbidity on mortality and quality of life in older adults with HIV

P. Ryan, A. Antela, I. Machuca, 2023, BMC Geriatrics.

HIV Coinfection Predicts Failure of Ledipasvir/Sofosbuvir in Treatment-Naïve Noncirrhotic Patients With HCV Genotype 1

J. Losa, J. Calleja, C. Fernández-Rodríguez, 2019, Open forum infectious diseases.

Reinfection by hepatitis C virus following effective all-oral direct-acting antiviral drug therapy in HIV/hepatitis C virus coinfected individuals.

J. Losa, J. Troya, J. Berenguer, 2019, AIDS.

Prevalence of M184V and K65R in proviral DNA from PBMCs in HIV-infected youths with lamivudine/emtricitabine exposure

P. Soler-Palacín, Á. Holguín, J. Losa, 2021, The Journal of antimicrobial chemotherapy.

Long-term control of HIV replication with dolutegravir and pegylated interferon alpha-2a in an HIV-infected patient with sixtuple-class resistance.

J. Schapiro, J. Arribas, S. García-Bujalance, 2014, AIDS.

Persistently altered liver test results in hepatitis C patients after sustained virological response with direct‐acting antivirals

J. Troya, P. Ryan, F. Pulido, 2018, Journal of viral hepatitis.

Dual Therapy With Darunavir and Ritonavir Plus Lamivudine vs Triple Therapy With Darunavir and Ritonavir Plus Tenofovir Disoproxil Fumarate and Emtricitabine or Abacavir and Lamivudine for Maintenance of Human Immunodeficiency Virus Type 1 Viral Suppression: Randomized, Open-Label, Noninferiority DU

D. Podzamczer, B. Clotet, E. Negredo, 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Boceprevir plus pegylated interferon/ribavirin to re-treat hepatitis C virus genotype 1 in HIV-HCV co-infected patients: final results of the Spanish BOC HIV-HCV Study.

A. Cruceta, J. Mallolas, M. Laguno, 2016, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

Lipid disorders in antiretroviral-naive patients treated with lopinavir/ritonavir-based HAART: frequency, characterization and risk factors.

J. Arribas, J. Peña, E. Navas, 2005, The Journal of antimicrobial chemotherapy.

Telaprevir-based therapy in patients coinfected with chronic hepatitis C virus infection and HIV: INSIGHT study.

A. Horban, S. Ouwerkerk-Mahadevan, J. Sasadeusz, 2016, The Journal of antimicrobial chemotherapy.

Physicians' opinions on generic antiretroviral drugs and single-tablet regimen de-simplification for the treatment of HIV infection: a multicentre survey in Spain.

P. L. López, Miguel Ángel Martínez, D. Podzamczer, 2019, The Journal of antimicrobial chemotherapy.

Impact of preexisting nucleos(t)ide reverse transcriptase inhibitor resistance on the effectiveness of bictegravir/emtricitabine/tenofovir alafenamide in treatment experience patients

J. Arribas, V. Moreno, R. Montejano, 2022, AIDS (London, England).

Inflammatory, procoagulant markers and HIV residual viremia in patients receiving protease inhibitor monotherapy or triple drug therapy: a cross-sectional study

J. Arribas, J. Mingorance, J. González-García, 2014, BMC Infectious Diseases.

The natural history of liver cirrhosis in HIV–hepatitis C virus-coinfected patients

C. Tural, J. Arribas, C. Quereda, 2011, AIDS.

Identification and validation of clinical phenotypes with prognostic implications in patients admitted to hospital with COVID-19: a multicentre cohort study

A. Borobia, D. Podzamczer, Á. Soriano, 2021, The Lancet. Infectious diseases.

Impact of Nucleos(t)ide Reverse Transcriptase Inhibitors on Blood Telomere Length Changes in a Prospective Cohort of Aviremic HIV–Infected Adults

B. Rodés, R. Perona, J. Arribas, 2018, The Journal of infectious diseases.

Change in metabolic parameters after switching from triple regimens with tenofovir alafenamide to dolutegravir‐based dual therapy. Bi‐lipid study

M. Díaz-Almirón, R. Montejano, L. Martín-Carbonero, 2022, HIV medicine.

Hepatocellular carcinoma risk in hepatitis C stage‐3 fibrosis after sustained virological response with direct‐acting antivirals

C. Fernández-Rodríguez, L. Bonet, G. Cuevas, 2021, Liver international : official journal of the International Association for the Study of the Liver.

Neurocognitive safety after 96 weeks on dual therapy with atazanavir/ritonavir plus lamivudine: results of the neurocognitive substudy of the SALT randomized clinical trial

J. De La Torre, J. Prada, S. Reus, 2018, The Journal of antimicrobial chemotherapy.

Reinfection by HCV following effective all-oral DAA therapy in HIV/HCV-coinfected individuals.

J. Losa, J. Troya, J. Berenguer, 2018, AIDS.

Epidemiological characteristic and prognosis changes in chronic hepatitis B in people living with HIV.

J. Arribas, V. Moreno, L. Martín-Carbonero, 2023, Enfermedades infecciosas y microbiologia clinica.

Pegylated interferon {alpha}2a plus ribavirin versus pegylated interferon {alpha}2b plus ribavirin for the treatment of chronic hepatitis C in HIV-infected patients.

C. Tural, J. Mallolas, C. Quereda, 2009, The Journal of antimicrobial chemotherapy.

Impact of Pre-Existing Nrti Resistance on the Effectiveness of Bictegravir/Emtricitabine/Tenofovir Alafenamide in Treatment Experience Patients: Real-World Data.

J. Arribas, V. Moreno, R. Montejano, 2022, AIDS (London).

Reinfection by HCV following effective all-oral DAA therapy in HIV/HCV-coinfected individuals.

J. Losa, J. Troya, J. Berenguer, 2019, AIDS.

Sustained virological response to interferon plus ribavirin reduces non-liver-related mortality in patients coinfected with HIV and Hepatitis C virus.

J. Mallolas, C. Quereda, F. Pulido, 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Expanding HIV clinical monitoring: the role of CD4, CD8, and CD4/CD8 ratio in predicting non-AIDS events

Miguel Ángel Martínez, B. Rodés, E. Poveda, 2023, EBioMedicine.

Effectiveness and safety of first-line antiretroviral regimens in clinical practice: a multicentre cohort study.

Miguel Ángel Martínez, D. Podzamczer, C. Vidal, 2020, The Journal of antimicrobial chemotherapy.

Executive summary of the GeSIDA/National AIDS Plan consensus document on antiretroviral therapy in adults infected by the human immunodeficiency virus (updated January 2018).

D. Podzamczer, E. Negredo, J. Miro, 2019, Enfermedades infecciosas y microbiologia clinica.

Longitudinal comparison of inflammatory, coagulation and metabolic biomarkers in patients who start ART versus patients who remain ART‐naïve

J. González-García, M. Montes, I. Pérez-Valero, 2012 .